Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Calculating radiotherapy margins based on Bayesian modelling of patient specific random errors.
Herschtal A, Te Marvelde L, Mengersen K, Hosseinifard Z, Foroudi F, Devereux T, Pham D, Ball D, Greer PB, Pichler P, Eade T, Kneebone A, Bell L, Caine H, Hindson B, Kron T. Herschtal A, et al. Among authors: hindson b. Phys Med Biol. 2015 Mar 7;60(5):1793-805. doi: 10.1088/0031-9155/60/5/1793. Epub 2015 Feb 6. Phys Med Biol. 2015. PMID: 25658193
Australian & New Zealand Faculty of Radiation Oncology Genito-Urinary Group: 2011 consensus guidelines for curative radiotherapy for urothelial carcinoma of the bladder.
Hindson BR, Turner SL, Millar JL, Foroudi F, Gogna NK, Skala M, Kneebone A, Christie DR, Lehman M, Wiltshire KL, Tai KH; RANZCR Faculty of Radiation Oncology Genito-Urinary Group (FROGG). Hindson BR, et al. J Med Imaging Radiat Oncol. 2012 Feb;56(1):18-30. doi: 10.1111/j.1754-9485.2011.02336.x. J Med Imaging Radiat Oncol. 2012. PMID: 22339742
Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial.
Huddart R, Hafeez S, Griffin C, Choudhury A, Foroudi F, Syndikus I, Hindson B, Webster A, McNair H, Birtle A, Varughese M, Henry A, McLaren DB, Parikh O, Nikapota A, Tang C, Patel E, Miles E, Warren-Oseni K, Kron T, Hill C, Philipps L, Vassallo-Bonner C, Cheung KC, Gribble H, Lewis R, Hall E. Huddart R, et al. Among authors: hindson b. Eur Urol. 2025 Jan;87(1):60-70. doi: 10.1016/j.eururo.2024.09.006. Epub 2024 Oct 7. Eur Urol. 2025. PMID: 39379236 Free article. Clinical Trial.
Acute Toxicity of Hypofractionated and Conventionally Fractionated (Chemo)Radiotherapy Regimens for Bladder Cancer: An Exploratory Analysis from the RAIDER Trial.
Huddart R, Hafeez S, Omar A, Alonzi R, Birtle A, Cheung KC, Choudhury A, Foroudi F, Gribble H, Henry A, Hilman S, Hindson B, Lewis R, Muthukumar D, McLaren DB, McNair H, Nikapota A, Olorunfemi A, Parikh O, Philipps L, Rimmer Y, Syndikus I, Tolentino A, Varughese M, Vassallo-Bonner C, Webster A, Griffin C, Hall E. Huddart R, et al. Among authors: hindson b. Clin Oncol (R Coll Radiol). 2023 Sep;35(9):586-597. doi: 10.1016/j.clon.2023.05.002. Epub 2023 May 9. Clin Oncol (R Coll Radiol). 2023. PMID: 37225552 Clinical Trial.
Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New Zealand.
Pryor DI, Martin JM, Millar JL, Day H, Ong WL, Skala M, FitzGerald LM, Hindson B, Higgs B, O'Callaghan ME, Syed F, Hayden AJ, Turner SL, Papa N. Pryor DI, et al. Among authors: hindson b. JAMA Netw Open. 2021 Nov 1;4(11):e2129647. doi: 10.1001/jamanetworkopen.2021.29647. JAMA Netw Open. 2021. PMID: 34724555 Free PMC article.
37 results